.gif){kind=logo}
Monday, April 28- PDUFA date for Genentech, Inc. (NYSE: DNA) and Roche Holding Ltd. (OTC: RHHBY)'s supplemental Biologics License Application for Herceptin for label expansion to include AC followed by docetaxel in treatment of adjuvant HER2+ breast cancer.
- PDUFA date for Shire plc (NASDAQ: SHPGY) and New River Pharma's supplemental New Drug Application for Vyvanse (NRP-104) treatment of Attention Deficit Hyperactivity Disordre, or ADHD, in adult patients 18-55 years old; the drug is already approved for pediatric ADHD ages 6-12.
- Verizon Communications Inc. (NYSE: VZ) to report Q earnings; conference call at 8:30am.
- Tyson Foods, Inc. (NYSE: TSN) to report Q2 earnings; conference call at 9:00am.
- Two-day FOMC meeting beginning at 8:30am.
- PDUFA date for Merck & Co., Inc. (NYSE: MRK)'s New Drug Application for Cordaptive (MK-0524A) adjunctive therapy to diet for treating elevated LDL Cholesterol, low HDL Cholesterol and elevated triglycerides levels.
- PDUFA date for Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP)'s supplemental New Drug Application for dose of 8mg treatment of Irritable Bowel Syndrome with Constipation; already approved for Chronic Idiopathic Constipation at 24ug dosage.
- BP plc (NYSE: BP) to report Q1 earnings; conference call at 10:15am.
- United States Steel Company (NYSE: X) to report Q1 earnings; conference call at 2:00pm.
Wednesday, April 30
- Second day of two-day FOMC meeting.
- Kraft Foods, Inc. (NYSE: KFT) to report Q1 earnings; conference call at 8:00am.
- Akamai Technologies, Inc. (NASDAQ: AKAM) to report Q1 earnings; conference call at 4:30pm.
- Starbucks Corporation (NASDAQ: SBUX) to report Q2 earnings; conference call at 5:00pm.
- PDUFA date for Discovery Laboratories, Inc. (NASDAQ: DSCO). On Nov 16, 2007, FDA established May 1, 2008 as its target date to complete its review of Surfaxin New Drug Application for prevention of Respiratory Distress Syndrome in premature infants.
- Comcast Corporation (NASDAQ: CMCSA) to report Q1 earnings; conference call at 8:30am.
- Exxon Mobil Corporation (NYSE: XOM) to report Q1 earnings; conference call at 11:00am.
- SEC Advisory Committee to meet at 9:00am on Improvements to Financial Reporting.
- PDUFA Date for The Medicines Company (NASDAQ: MDCO) New Drug Application, NDA for Cleviprex for treatment of Hypertension.
- PDUFA Date for Akorn, Inc. (NASDAQ: AKRX) for Akten Ophthalmic Gel, an ocular anesthesia.
Cramer on BloggingStocks: Intel has spoken 
Former GM CEO settles for a less ridiculous retirement package
Intel has strong Q2, revenues up 12%
